Place de cotation: Londres  (Grande-Bretagne)

The Group's principal activity is developing, marketing and distributing pharmaceutical products. The Group offers a range of 34 acquired and licensed, prescription brands across a range of therapeutic categories, including dermatology, childbirth, the prevention of heart disease, nutrition and in the treatment of Parkinson disease. Brands are Nu-Seals, Forceval, Hydromal, Syntocinon, Symmetrel, Deltacortril, Syntometrine, Naseptin, Atarax and Periostat.

Copyright  2016